Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Isoforms | 2 | 2013 | 121 | 0.350 |
Why?
|
| Antibodies, Monoclonal | 3 | 2007 | 282 | 0.340 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 23 | 0.300 |
Why?
|
| Mutagenesis | 1 | 2006 | 87 | 0.290 |
Why?
|
| Down-Regulation | 1 | 2006 | 420 | 0.250 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 756 | 0.220 |
Why?
|
| Epidermal Growth Factor | 3 | 2013 | 63 | 0.220 |
Why?
|
| Neoplasms | 2 | 2013 | 1033 | 0.180 |
Why?
|
| Receptor, erbB-2 | 3 | 2009 | 122 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2009 | 209 | 0.160 |
Why?
|
| Breast Neoplasms | 3 | 2015 | 1426 | 0.140 |
Why?
|
| Cell Line, Tumor | 5 | 2009 | 2128 | 0.140 |
Why?
|
| Plants, Medicinal | 1 | 2015 | 54 | 0.130 |
Why?
|
| Transforming Growth Factor alpha | 3 | 2008 | 16 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 107 | 0.120 |
Why?
|
| Integrins | 1 | 2013 | 49 | 0.120 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2013 | 23 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2015 | 250 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 7 | 0.090 |
Why?
|
| Receptor, erbB-3 | 1 | 2009 | 11 | 0.090 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2009 | 18 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2009 | 23 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2009 | 52 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 53 | 0.090 |
Why?
|
| Mice, Nude | 2 | 2006 | 323 | 0.090 |
Why?
|
| Ligands | 2 | 2007 | 317 | 0.090 |
Why?
|
| Phenylmercuric Acetate | 1 | 2008 | 2 | 0.080 |
Why?
|
| Vanadates | 1 | 2008 | 7 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 39 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 47 | 0.080 |
Why?
|
| Animals | 6 | 2015 | 14307 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2008 | 257 | 0.080 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 129 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2008 | 110 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 383 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2008 | 423 | 0.080 |
Why?
|
| Binding Sites, Antibody | 1 | 2006 | 19 | 0.070 |
Why?
|
| Antibodies, Blocking | 1 | 2006 | 11 | 0.070 |
Why?
|
| Cattle | 1 | 2008 | 472 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 117 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1124 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 82 | 0.070 |
Why?
|
| Peptides | 1 | 2008 | 308 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1490 | 0.070 |
Why?
|
| Cell Survival | 1 | 2006 | 818 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 336 | 0.050 |
Why?
|
| Mice | 3 | 2007 | 5668 | 0.050 |
Why?
|
| Mutation | 1 | 2006 | 1023 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2007 | 1802 | 0.050 |
Why?
|
| Humans | 6 | 2015 | 34853 | 0.050 |
Why?
|
| Female | 5 | 2015 | 19873 | 0.040 |
Why?
|
| Artemia | 1 | 2015 | 14 | 0.030 |
Why?
|
| Lethal Dose 50 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Solvents | 1 | 2015 | 93 | 0.030 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2013 | 14 | 0.030 |
Why?
|
| CHO Cells | 1 | 2013 | 107 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2013 | 82 | 0.030 |
Why?
|
| Cricetinae | 1 | 2013 | 217 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 195 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 984 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2015 | 1352 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 132 | 0.020 |
Why?
|
| Cell Division | 1 | 2009 | 296 | 0.020 |
Why?
|
| Quinazolines | 1 | 2006 | 31 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 550 | 0.020 |
Why?
|
| Morpholines | 1 | 2006 | 65 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 649 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2006 | 242 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 391 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2006 | 878 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 642 | 0.010 |
Why?
|
| Cell Movement | 1 | 2006 | 545 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1149 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 1317 | 0.010 |
Why?
|